TOCQUEVILLE ASSET MANAGEMENT L.P.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 883961
New York, NY
Position in REGN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$12,191,486
-$23,950,554 QoQ
Shares Held
15,779
-66.3% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TOCQUEVILLE ASSET MANAGEMENT L.P. holds $35,568,620 across 14 Biotechnology names. REGN ranks #2 (34.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
219,220 | $16,461,229 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
15,779 | $12,191,486 | |
| 3 | CSBR |
Champions Oncology, Inc.
|
319,674 | $1,838,125 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
18,825 | $1,397,944 | |
| 5 | IMMX |
Immix Biopharma, Inc.
|
89,550 | $815,800 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
4,200 | $709,884 | |
| 7 | MGTX |
MeiraGTx Holdings plc
|
68,200 | $590,612 | |
| 8 | RARE |
Ultragenyx Pharmaceutical Inc.
|
23,850 | $499,657 |
All Filings in REGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,191,486 | 15,779 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $36,142,040 | 46,824 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $30,485,154 | 54,218 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $32,078,550 | 61,102 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $54,498,749 | 85,929 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||